Brainsway Ltd.
BRSYF- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001505065
No open-market purchases or sales by Brainsway Ltd. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesBWAY
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BRSYF, Q2 2026
No superinvestor reported holding BRSYF at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Brainsway Ltd. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | Jun 15 | 7 daysLate | Moiseyev GiladChief Technology Officer | SSale | −5.00K | – | – | −8.6%53.1K after | |
| Jun 3, 2026 (view filing) | Jun 1-2 | 2 days | Roth YiftachChief Scientist | SSale | −7.00K | – | – | −0.6%1.07M after | 4 lots |
| May 26, 2026 (view filing) | May 25-26 | 1 day | Mitrany Rayten Michal EtyDirector | SSale | −18.0K | – | – | −59.0%12.5K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Brainsway Ltd. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding BRSYF in 13F filings for Q2 2026.